Bill's Page Views

This Week: 2   All-Time: 149

H.J.Res.54

0 Comments

My Vote  All Votes
AyeAyes:0
NayNays:0

Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services within the Department of Health and Human Services relating to Medicare coverage for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions.

Other Bill Titles (2 more)

9/27/2007--Introduced.
Disapproves a specified rule submitted by the Centers for Medicare & Medicaid Services of the Department of Health and Human Services relating to Medicare coverage for the use of erythropoiesis stimulating agents in cancer and related neoplastic condition... moreSee Full Bill Text

Sponsor

Amendments

This bill has no amendments.



Bill Status

Make a Bill Status Widget Question
IntroducedresultVoted on by House
September 27, 2007
Show All Actions (6 actions)


Show More User Statistics...


In the News feed

October 19, 2007 FDA Agrees With CMS’ Coverage Decision on ESAs

recently introduced HJ Res. 54, which would reverse CMS’ national coverage decision. The Senate passed a resolution by unanimous consent asking the CMS to ...

Was this article useful? Yes or No

Source: FDA news (subscription), VA


October 18, 2007 Groups Ask Congress Not To Intervene in CMS Decision on Anemia Drugs

introduced a Congressional Review Act joint resolution (HJ Res 54) that would require CMS to reverse the decision. Amgen, J&J, the American Society of ...

Was this article useful? Yes or No

Source: Kaiser network.org, DC


October 02, 2007 CMS Required To Reverse Medicare Coverage Decision For Anemia ...

on Thursday introduced a bill (HJ Res 54) that would reverse a CMS decision to limit Medicare coverage for use of anemia medications -- Aranesp, ...

Was this article useful? Yes or No

Source: eMaxHealth.com, NC


1 more articles...
See most useful news articles

Blog Coverage feed

November 16, 2007 25 new messages in 14 topics - digest

joint resolution (HJ Res. 54) is sponsored by Rep. Anna Eshoo (D-CA), whose district includes Amgen's headquarters. It already has 26 co-sponsors. The resolution is adamantly supported by the American Society of Clinical Oncologists ...

Was this article useful? Yes or No

Source: health.alternative & fitness.weights


October 19, 2007 Congress Asked Not To Intervene In CMS Decision On Anemia Drugs

introduced a Congressional Review Act joint resolution (HJ Res 54) that would require CMS to reverse the decision. Amgen, J&J, the American Society of Clinical Oncology, the American Society of Hematology, patient advocacy groups, ...

Was this article useful? Yes or No

Source: Golden Doctor ))) Blog Health Help.


October 18, 2007 Congress Asked Not To Intervene In CMS Decision On Anemia Drugs

introduced a Congressional Review Act joint resolution (HJ Res 54) that would require CMS to reverse the decision. Amgen, J&J, the American Society of Clinical Oncology, the American Society of Hematology, patient advocacy groups, ...

Was this article useful? Yes or No

Source: Buy Gold Tablet Blog Day


8 more posts...
See most useful blog posts

Information made available by:

Technorati

For more info about the campaign contributions behind this bill, visit its page on Maplight.org

OpenCongress is a joint project of the Participatory Politics Foundation and the Sunlight Foundation. Questions? Comments? Contact Us

Data made available by:

Govtrack.US

Help Open Up Congress:

The OpenHouse Project